[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.236.216.93. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 271
Citations 0
Correction
March 2018

Error in Results Section

JAMA Intern Med. 2018;178(3):439. doi:10.1001/jamainternmed.2018.0618

In the Research Letter “Characterizing Kaiser Permanente Southern California’s Experience With the California End of Life Option Act in the First Year of Implementation,”1 published online December 26, 2017, there was an error in the number of patients reported in the Results section. Where it previously read “Nearly 130 (74%) of patients who received the EOLOA drugs ingested them and died within a median of 9 days after the prescription was written,” it now reads “Sixty-eight (74%) of the 92 patients who received the EOLOA drugs ingested them and died within a median of 9 days after the prescription was written.” This article was previously corrected for a typographic error in the study flow chart.2

References
1.
Nguyen  HQ, Gelman  EJ, Bush  TA, Lee  JS, Kanter  MH.  Characterizing Kaiser Permanente Southern California’s experience with the California End of Life Option Act in the first year of implementation  [published online December 26, 2017].  JAMA Intern Med. doi:10.1001/jamainternmed.2017.7728.PubMedGoogle Scholar
2.
 Typographic error in figure  [published online February 5, 2018].  JAMA Intern Med. doi:10.1001/jamainternmed.2018.0093Google Scholar
×